Navigation Links
Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
Date:4/8/2013

ics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics, Inc. Prices Public Offering of Common Stock
2. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
3. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
4. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
5. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
6. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
7. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
8. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
9. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
10. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
11. Uroplasty Announces CEO Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ) ... Market in the US 2015-2019" report to their ... market in the US to grow at a CAGR ... report covers the present scenario and the growth prospects ... the period 2015-2019. To calculate the market size, the ...
(Date:7/6/2015)... 6, 2015 Array BioPharma,s (NASDAQ:   ... past weekend at the 2015 ESMO World Congress ... the meeting, data were shared from a Phase ... randomized Phase 2 expansion of that trial testing ... inhibitor, with or without the addition of alpelisib ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... , DEFUNIAK SPRINGS, Fla., Nov. 11 Professional Products, ... for nearly five decades, today announced its innovative new ... knee splint with a breathable, anti-migration wrap, the PKS ... from pain and edema in treating post-operative repairs, ligament ...
... WellTek/MedX Group, health, fitness and wellness companies, today announced ... facilitate becoming an SEC reporting company. , ... a wholly owned subsidiary of an SEC reporting public ... name to WellTek Incorporated. As a result of ...
Cached Medicine Technology:Knee Splint's Multi-Compartment Technology Speeds Rehabilitation from Injuries 2WellTek/MedX Group Completes Major Reorganization 2
(Date:7/6/2015)... Newport News, VA (PRWEB) , ... July 06, ... ... announced today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® ... Bon Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an ...
(Date:7/5/2015)... , ... July 06, 2015 , ... ... benefits market, is excited to announce the next generation of PrimeStar Individual Dental ... plans to now include two network options—Maximum Allowable Charge (MAC) and usual, customary ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck ... sufferers have pain located in the neck. Another 19% suffer from head, migraine, or ... literature suggests that 45% of American workers must deal with neck pain. ...
(Date:7/3/2015)... ... 03, 2015 , ... Brendon Burchard's new High Performance ... media attention. In an effort to spread the news, a comprehensive review of ... many people are feeling overwhelmed by stress and fatigue," reports Hendricks. "Many folks ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... is said to be vulnerable to a specific health ... colleagues from Institute for Clinical Evaluative Sciences in Toronto. ... more prone to pelvic fractures and Pisceans should be ... women born under the sign of Virgo vomit more ...
... to the survey conducted by India's National Family Health Survey, ... covers around 200,000 people and is the third one since ... indicates that infant mortality in rural areas is 62% while ... are 46% while in China it is only 8%. On ...
... has announced Nigeria's donation of $10 million to the ... HIV/AIDS, malaria and// tuberculosis. ,The President made ... of the Board of Friends of the Global Fund ... holding in Kigali, Rwanda, on Monday February 12. ...
... of the oral cavity even in low doses.// ... to counteract the production of acid between the teeth. ... reduction of the sugar xylose, or wood sugar. Xylitol occurs ... It is used in sugarless sweets, especially in chewing gum ...
... Indian doctors have so far returned home after failing to ... forced them to live with rats, cockroaches and scrounge for ... of 5,000 returning to India is since April 2006 when ... by the Indian medical community in court but a judicial ...
... bedtime, could make you sleep quicker,// says a new study. ... of Sydney studied 12 healthy men who were 18-35 years ... rice in their meals - plain rice, long-grain rice and ... rice has a high glycemic index - a ranking system ...
Cached Medicine News:Health News:Health Disorders Linked To Astrological Signs 2Health News:Xylitol Fights Oral Bacteria 2Health News:Indian Doctors Return Home from Britain, More on the Way 2Health News:Indian Doctors Return Home from Britain, More on the Way 3
The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
The Shaatz pessary, available in nine sizes, is used for a first to second degree prolapse and an accompanying cystocele....
... Burdick ABP Systems are among ... the market today, with advanced ... analysis of patient information. Extensive ... validated Burdick ABPM accuracy, making ...
The Capio CL Transvaginal Suture Capturing Device allows for a transvaginal suture fixation to Cooper's Ligament for sling procedures...
Medicine Products: